Scientists probe mucus barrier to unlock new lung treatment
NCT ID NCT06670937
Summary
This study aims to understand how the thick mucus in the lungs of people with bronchiectasis might block a potential new inhaled antibody treatment. Researchers will collect mucus samples from 30 adult patients to test in the lab how well the treatment can move through the mucus and fight bacteria. The goal is to gather information to help design better inhaled therapies for this chronic lung disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Tours
RECRUITINGTours, France, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.